Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Certain peptides have been studied for their potential to support the body's own regulatory and repair processes
GLP-1 Timeline: From Diabetes to Pediatric Weight Management 2005: First GLP-1 medications approved for Type 2 diabetes in adults 2014: FDA approves Saxenda (liraglutide) as the first GLP-1 for weight loss 2022: Wegovy approved for adolescents 12 and older 2023: American Academy of Pediatrics endorses GLP-1s for pediatric obesity 2025: FDA considering approval for children as young as 6 years old Though the FDA approved Saxenda as the first GLP-1 for weight loss back in 2014, it wasnt until the last few years that the popularity and availability of these medications for obesity have skyrocketed
Patients in areas with limited endocrinology or weight management specialists may find cash pay telehealth platforms provide better access to specialized care than local insurance-based options
Branded obesity medications carry significant price tags, and insurance coverage varies dramatically
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Discontinuing prescribed therapy may lead to a rebound in body weight
US$ 26.71
US$ 24.31
US$ 28.12
US$ 22.48
